Precipio, Inc. Common Stock (PRPO) is a publicly traded Healthcare sector company. As of July 26, 2026, PRPO trades at $23.68 with a market cap of $42.32M and a P/E ratio of -102.98. PRPO moved +3.50% today. Year to date, PRPO is +3.05%; over the trailing twelve months it is +61.31%. Its 52-week range spans $3.90 to $33.63. Rallies surfaces PRPO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Precipio Q1 Revenue Rises 30% to $6.71M; Adjusted EBITDA Falls to -$200K: Precipio Inc generated $6.71 million in Q1 revenue, up over 30% year-over-year, with pathology services revenue rising to over $6 million. Adjusted EBITDA swung to a $200,000 loss and gross margin fell to 40% from 47% as CMS fee cuts and timing issues weighed on profitability.
| Metric | Value |
|---|---|
| Price | $23.68 |
| Market Cap | $42.32M |
| P/E Ratio | -102.98 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.63 |
| 52-Week Low | $3.90 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $24.05M |
| Net Income | $-363.00K |
| Gross Margin | 44.52% |
PRPO analyst coverage data. Average price target: $0.00.